Shah, Shailja
Cappell, Katherine
Sedgley, Robert
Pelletier, Corey
Jacob, Rinu
Bonafede, Machaon
Yadlapati, Rena
Funding for this research was provided by:
Phathom Pharmaceuticals
Article History
Received: 15 November 2022
Accepted: 13 January 2023
First Online: 25 January 2023
Competing interests
: Dr. Shah is a consultant for Phathom Pharmaceuticals and RedHill Biopharma. Dr. Yadlapati is a consultant for Phathom Pharmaceuticals. Dr. Cappell, Mr. Sedgley, and Dr. Bonafede are employees of Veradigm. Dr. Pelletier and Dr. Jacob are employees of Phathom Pharmaceuticals.